Skip to main content
. 2019 Nov 3;9(1):1683347. doi: 10.1080/2162402X.2019.1683347

Figure 4.

Figure 4.

Identification of CD206 as a predictor of outcome in AML. (a and b) OS and EFS analyses based on mRNA expression levels of the four M2 marker genes (CD68, CD163, CD206, and CD204) in CN-AML patients from Cohort 2 (a) and Cohort 3 (b). Patients were stratified in two groups using the median expression value as a cutoff. The p-values were computed using log-rank tests.